Today's News |
|
Breaking: J&J's One-Shot Covid Vaccine Is Safe and Generates Promising Immune Response in Early Trial
Thursday, January 14, 2021
Vancouver, BC, January 14, 2021--Johnson & Johnson's one-dose coronavirus vaccine is safe and appears to generate a promising immune response in both young and elderly volunteers, according to trial data published Wednesday in the New England Journal of Medicine. Most of the volunteers produced detectable neutralizing antibodies, which researchers believe play an important role in defending cells against the virus, after 28 days, according to the trial data. By day 57, all volunteers had detectable antibodies, regardless of vaccine dose or age group.
|
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|